Andel's direct-to-employer model partners with Eli Lilly and other pharma companies to offer flexible, insurance-free GLP-1 access that benefits employers, patients, and manufacturers.
Jay Bregman
Advertisement
Articles by Jay Bregman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
2
Phase 3 MonumenTAL-3 Trial Demonstrates Significant Survival Benefit With Talquetamab-Based Regimens in Relapsed/Refractory Multiple Myeloma
3
Combined Food Policies, Including Labeling and Advertising Bans, Plausibly Reduce Childhood Obesity
4
Halfway There Is Nowhere
5